BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marlow LA, Rohl SD, Miller JL, Knauf JA, Fagin JA, Ryder M, Milosevic D, Netzel BC, Grebe SK, Reddi HV, Smallridge RC, Copland JA. Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts. J Clin Endocrinol Metab 2018;103:3169-82. [PMID: 29846633 DOI: 10.1210/jc.2017-01845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Novel anaplastic thyroid cancer PDXs and cell lines: Expanding preclinical models of genetic diversity. J Clin Endocrinol Metab 2021:dgab453. [PMID: 34147031 DOI: 10.1210/clinem/dgab453] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Jin Y, Liu M, Sa R, Fu H, Cheng L, Chen L. Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics. Cancer Lett 2020;469:35-53. [PMID: 31589905 DOI: 10.1016/j.canlet.2019.09.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
3 Liu CL, Hsu YC, Lee JJ, Chen MJ, Lin CH, Huang SY, Cheng SP. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Mol Cell Endocrinol 2020;499:110595. [PMID: 31563469 DOI: 10.1016/j.mce.2019.110595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wei W, Hardin H, Luo Q. Targeting autophagy in thyroid cancers. Endocrine-Related Cancer 2019;26:R181-94. [DOI: 10.1530/erc-18-0502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
5 Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE. Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clin Cancer Res 2019;25:3141-51. [PMID: 30737244 DOI: 10.1158/1078-0432.CCR-18-2953] [Cited by in Crossref: 35] [Cited by in F6Publishing: 46] [Article Influence: 11.7] [Reference Citation Analysis]
6 Schweppe RE, Pozdeyev N, Pike LA, Korch C, Zhou Q, Sams SB, Sharma V, Pugazhenthi U, Raeburn C, Albuja-Cruz MB, Reigan P, LaBarbera DV, Landa I, Knauf JA, Fagin JA, Haugen BR. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Mol Cancer Res 2019;17:1036-48. [PMID: 30733375 DOI: 10.1158/1541-7786.MCR-18-1026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]